| abstract |
The present invention provides a composition for preventing or treating metabolic disease selected from the group consisting of obesity, dyslipidemia and fatty liver comprising oat oxide beta-glucan as an active ingredient. The composition containing the oat-derived beta-glucan as an active ingredient of the present invention inhibits adipocyte differentiation, decreases body fat mass, decreases visceral fat mass, decreases total cholesterol concentration, decreases plasma triglyceride and liver triglyceride , Ultimately exhibiting an activity of preventing or treating obesity, hyperlipidemia or fatty liver. |